Md. Weil et al., INFLUENCE OF A CHILDS SEX ON MEDULLOBLASTOMA OUTCOME, JAMA, the journal of the American Medical Association, 279(18), 1998, pp. 1474-1476
Context.-Aggressive treatment of medulloblastoma, the most common pedi
atric brain tumor, has not improved survival. Identifying better progn
ostic indicators may warrant less morbid therapy. Objective.-To invest
igate the role of sex on outcome of medulloblastoma. Design.-Retrospec
tive study of significant factors for survival with a median follow-up
of 82 months. Setting.-University medical center. Patients.-A total o
f 109 consecutive, pediatric patients treated for primary medulloblast
oma from 1970 to 1995 with surgery and postoperative radiotherapy and,
after 1979, chemotherapy. Main Outcome Measures.-Factors independentl
y associated with survival. Results.-The final multivariate model pred
icting improved survival included sex (hazard ratio, 0.52; 95% confide
nce interval [CI], 0.29-0.92; P=.03; favoring female), metastases at p
resentation (hazard ratio, 2.01,95% CI, 1.14-3.52; P=.02), and extent
of surgical resection (hazard ratio, 0.60; 95% CI, 0.34-1.04; P=.07; f
avoring greater resection). The overall, 5-year freedom from progressi
on was 40% and survival was 49%. Radiotherapy dose (P=.72), and chemot
herapy (P=.90) did not significantly affect a disease outcome. Conclus
ions.-The sex of the child was an important predictor for survival of
medulloblastoma; girls had a much better outcome. The difference in su
rvival between sexes should be evaluated in prospective, clinical tria
ls.